These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6163380)

  • 1. Interferon--a system of medium quantity production for therapeutic use.
    Warren SL
    Ann Allergy; 1981 Apr; 46(4):216-21. PubMed ID: 6163380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perspectives on interferon research and on its therapeutic use].
    Montagnier L
    Arch Inst Pasteur Tunis; 1981; 58(3):297-312. PubMed ID: 6172080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a new highly standardised, lab-independent whole-blood leukocyte function assay for clinical trials (ILCS).
    Schmolz M; Hurst TL; Bailey DM; Powell JR; Forsey RJ; Thompson JM; Williams C; Pawelec G
    Exp Gerontol; 2004 Apr; 39(4):667-71. PubMed ID: 15050304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
    Billiau A
    J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
    Edelbroek PM; van der Heijden J; Stolk LM
    Ther Drug Monit; 2009 Jun; 31(3):327-36. PubMed ID: 19349929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory sampling. Does the process affect the outcome?
    Becan-McBride K
    J Intraven Nurs; 1999; 22(3):137-42. PubMed ID: 10640077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A brief history of interferon's trajectory to clinical application, and personal reminiscences of a large-scale human interferon production initiative.
    Billiau A
    Verh K Acad Geneeskd Belg; 2009; 71(1-2):15-42. PubMed ID: 19739396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction: the interferon system.
    Stinebring WR
    In Vitro Monogr; 1974; (3):1-3. PubMed ID: 4471017
    [No Abstract]   [Full Text] [Related]  

  • 11. Semi-crude human leukocyte interferon production in a simple medium.
    Tóth M; Mécs I; Tóth S; Endrész V; Béládi I
    Acta Microbiol Hung; 1984; 31(1):61-7. PubMed ID: 6331049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human interferons -- features and chances (author's transl)].
    Pohl A; Moser K; Micksche M
    Wien Klin Wochenschr; 1981 Jul; 93(14):439-57. PubMed ID: 6168122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel interferons for treatment of hepatitis C virus.
    Clark V; Nelson DR
    Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential mRNA expression and production of interleukin-4 and interferon-gamma in stimulated peripheral blood mononuclear cells of house-dust mite-allergic patients.
    Laan MP; Baert MR; Vredendaal AE; Savelkoul HF
    Eur Cytokine Netw; 1998 Mar; 9(1):75-84. PubMed ID: 9613681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferons: basic research, clinical studies, and their support.
    Friedman RM
    Arch Pathol Lab Med; 1982 Jun; 106(6):259-60. PubMed ID: 6178383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of interferon action.
    Schwarz LA; Fleischmann WR
    Tex Rep Biol Med; 1981-1982; 41():298-306. PubMed ID: 6184817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon.
    Moore GE
    Surg Gynecol Obstet; 1981 Jul; 153(1):97-102. PubMed ID: 6166059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The antibacterial efficacy of preparations of interferon and its inducers].
    Spivak NIa; Grabchenko NI; Lazarenko LN; Tovt-Korshinskaia MI; Ganova LA; Timoshok NA; Krivokhatskaia LD; Mikhaĭlenko ON; Karpov AV; Mikhaĭlenko TI; Zotsenko VN
    Mikrobiol Z; 1999; 61(1):32-45. PubMed ID: 10330873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The purification and manufacture of human interferons. Their promise is still not fulfilled, but now their genes have been isolated and cloned in E. coli. The bacteria are making interferon in quantity and the bacterial product is undergoing clinical trials.
    Pestka S
    Sci Am; 1983 Aug; 249(2):37-43. PubMed ID: 6194559
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon as therapeutic agent.
    Borecký L; Fuchsberger N
    Acta Virol; 1983 Jul; 27(4):359-70. PubMed ID: 6195902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.